Free Trial
OTCMKTS:BLOZF

Cannabix Technologies Q2 2026 Earnings Report

Cannabix Technologies logo
$0.25 -0.02 (-7.74%)
As of 02:05 PM Eastern

Cannabix Technologies EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cannabix Technologies Revenue Results

Actual Revenue
$0.09 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cannabix Technologies Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Cannabix Technologies Earnings Headlines

Cannabix Technologies Inc. (OTCMKTS:BLOZF) Short Interest Update
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
Cannabix Technologies Inc BLOZF
See More Cannabix Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cannabix Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cannabix Technologies and other key companies, straight to your email.

About Cannabix Technologies

Cannabix Technologies (OTCMKTS:BLOZF) is a Canadian technology company focused on developing breath-testing systems for detecting cannabis and other drugs. Its work is aimed primarily at law-enforcement, workplace-safety and occupational-testing applications, where portable tools may help identify recent drug use through breath samples.

The company’s principal development effort is the Cannabix Marijuana Breathalyzer, a device designed to detect tetrahydrocannabinol (THC), the principal psychoactive compound in cannabis. Cannabix has also researched breath-sample collection systems and analytical technologies, including platforms intended to support the detection of additional substances. The company’s products remain subject to development, testing and potential regulatory or commercial requirements.

Cannabix Technologies is based in Vancouver, British Columbia, and serves an international market opportunity through its focus on drug-impaired-driving enforcement and workplace testing. The company is led by Chief Executive Officer and Director Rav Mlait. Its shares trade in the United States under the symbol BLOZF.

View Cannabix Technologies Profile